Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò"

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease3 trials
• Polycystic kidney disease2 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Mario Negri Institute for Pharmacological Research5 trials

Running trials

• Recruiting

  Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases

  NCT05996731· Mario Negri Institute for Pharmacological Research· Source

  Contact: Elena Bresin

• Active, not recruiting

  Multiparametric MRI in Healthy Volunteers and CKD Patients

  NCT05229263· Mario Negri Institute for Pharmacological Research· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Polycystic kidney disease1 recruiting

Closed trials

• Terminated

  Patiromer Trial in CKD Stage IIIB to V

  NCT05786469· Phase 3· Mario Negri Institute for Pharmacological Research· Source

• Completed

  Thyroid Hormones in ADPKD

  NCT05646420· Mario Negri Institute for Pharmacological Research· Source

• Completed

  Dapagliflozin in Non-diabetic Stage IV CKD

  NCT04794517· Phase 2· Mario Negri Institute for Pharmacological Research· Source